Scinovex
article Open AccessTop 10% cited

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact

Alimentary Pharmacology & Therapeutics · 2005 · Vol. 21(11) · pp. 1365–1375
A. P. S. HunginLin ChangG. Richard LockeEslie DennisVictoria Barghout

Abstract

Most (76.6%) irritable bowel syndrome sufferers in the US are undiagnosed. Irritable bowel syndrome has a substantial impact on sufferers' well-being and health, with considerable socioeconomic consequences.

Gastrointestinal motility and disordersCongenital gastrointestinal and neural anomaliesInfant Health and DevelopmentIrritable bowel syndromeMedicineConstipationAbdominal painInternal medicineGastrointestinal disorderFunctional gastrointestinal disorderPhysical therapyPsychiatry

MeSH terms

Activities of Daily LivingAdultAgedAttitude to HealthFemaleHealth ResourcesHealth StatusHumansLife StyleMaleMiddle AgedPatient Acceptance of Health CareUnited StatesPrevalenceIrritable Bowel Syndrome

Funding

  • Novartis
  • Novartis Pharma
Citations
487
FWCI
8.09
field-weighted impact
References
38
Percentile
98%
vs. same field & year
Citations per year
Cited by
Review article: the economic impact of the irritable bowel syndrome
Alimentary Pharmacology & Therapeutics · 2014 · 446 citations
References
Impact of irritable bowel syndrome on quality of life
Digestive Diseases and Sciences · 1996 · 295 citations
U. S. Householder survey of functional gastrointestinal disorders
Digestive Diseases and Sciences · 1993 · 2,201 citations
The burden of selected digestive diseases in the United States
Gastroenterology · 2002 · 1,507 citations
AGA technical review on irritable bowel syndrome
Gastroenterology · 2002 · 1,401 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.